YU7396A - New pharmaceutical dosage form with one inhibitor of protone pump and at least one antibacterical composition and process for preparation - Google Patents
New pharmaceutical dosage form with one inhibitor of protone pump and at least one antibacterical composition and process for preparationInfo
- Publication number
- YU7396A YU7396A YU7396A YU7396A YU7396A YU 7396 A YU7396 A YU 7396A YU 7396 A YU7396 A YU 7396A YU 7396 A YU7396 A YU 7396A YU 7396 A YU7396 A YU 7396A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- dosage form
- preparation
- pharmaceutical dosage
- inhibitor
- antibacterical
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Pronalazak se odnosi na jedan oralni farmaceutski dozni oblik koji sadrži jedan inhibitor protonske pumpe i najmanje jedno protivbakterijsko jedinjenje u čvrstoj formulaciji kao i na postupak za njegovu izradu. Čvrsta formulacija je u vidu tablete prevučene enteričkom oblogom, kapsule ili višejediničnog doznog oblika u tabletama. Aktivna je materija omeprazol ili njegovi pojedinačni enantiomeri ili njegova alkalna so, ili lansoprazol, dok je protivbakterijsko jedinjenje amoksicilin i/ili klaritromicin i/ili metronidazol. Najpreporučljiviji je višejedinični dozni oblik. Nova čvrsta formulacija je posebno pogodna kod lečenja poremećaja povezanih sa Helicobacter infekcijama.The invention relates to an oral pharmaceutical dosage form containing one proton pump inhibitor and at least one antibacterial compound in a solid formulation and to a process for its preparation. The solid formulation is in the form of enteric coated tablets, capsules or multi-unit dosage forms in tablets. The active substance is omeprazole or its individual enantiomers or its alkali salt or lansoprazole, while the antibacterial compound is amoxicillin and / or clarithromycin and / or metronidazole. The most preferred is a multi-unit dosage form. The new solid formulation is particularly suitable for the treatment of disorders associated with Helicobacter infections.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9500422A SE9500422D0 (en) | 1995-02-06 | 1995-02-06 | New oral pharmaceutical dosage forms |
Publications (1)
Publication Number | Publication Date |
---|---|
YU7396A true YU7396A (en) | 1998-08-14 |
Family
ID=47598445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU7396A YU7396A (en) | 1995-02-06 | 1996-02-06 | New pharmaceutical dosage form with one inhibitor of protone pump and at least one antibacterical composition and process for preparation |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR100399524B1 (en) |
TN (1) | TNSN96025A1 (en) |
YU (1) | YU7396A (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5128140A (en) * | 1991-01-14 | 1992-07-07 | The Procter & Gamble Company | Swallowable pharmaceutical compositions |
-
1996
- 1996-02-02 KR KR1019960705556A patent/KR100399524B1/en not_active IP Right Cessation
- 1996-02-05 TN TNTNSN96025A patent/TNSN96025A1/en unknown
- 1996-02-06 YU YU7396A patent/YU7396A/en unknown
Also Published As
Publication number | Publication date |
---|---|
TNSN96025A1 (en) | 2005-03-15 |
KR100399524B1 (en) | 2004-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU70196A (en) | Effervescent tablet dosage forms and process for preparation thereof | |
SE9500422D0 (en) | New oral pharmaceutical dosage forms | |
NO20012222L (en) | Pharmaceutical formulation including omeprazole | |
TR199500825A2 (en) | Multi-unit pharmaceutical preparation. | |
NO20023313D0 (en) | Newly substituted benzimidazole dosage forms and methods for using the same | |
EE04800B1 (en) | Oral dosage form for acid unstable active ingredient, unit dosage form, method of preparation and use, and method for oral dosage form | |
IT1246383B (en) | METHOD FOR MASKING THE TASTE OF DRUGS | |
MX9600857A (en) | Multiple unit tableted dosage form i. | |
IT1245761B (en) | PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY. | |
NO2000010I1 (en) | Pharmaceutically acceptable salts of esomeprazole | |
EE200000096A (en) | Pharmaceutical preparation containing the active substance clodronate and siliconized microcrystalline cellulose as excipient | |
NO20060786L (en) | Pharmaceutical preparations with swelling coating | |
RS50298B (en) | Directly compressibile matrix for controlled release of single daily doses of clarithromycin | |
SE8804628D0 (en) | NEW COMPOUNDS | |
IS3789A7 (en) | Method of Preparation of Dosage in Solid Formed Temporary Release of Active Component | |
NO912414L (en) | RELATIONSHIP WITH MAGIC ACID INHIBITING EFFECT AND PROCEDURE FOR ITS MANUFACTURING. | |
ATE329589T1 (en) | MULTIPARTICULAR BISOPROLOL FORMULATION | |
YU7396A (en) | New pharmaceutical dosage form with one inhibitor of protone pump and at least one antibacterical composition and process for preparation | |
WO2002056867A3 (en) | Extended release pharmaceutical compositions containing beta-lactam antibiotics | |
EE03954B1 (en) | Method for the preparation of the carbamazepine sustained release dosage form | |
GB9420748D0 (en) | 1,5 benzodiazepine derivatives | |
AR028929A1 (en) | PROCEDURE TO PREPARE STABLE PHARMACEUTICAL COMPOSITIONS OF THE TYPE COMPRESSED CONTAINING OMEPRAZOL, SODIUM ALGINATE AND A BASIC AMINO ACID AND PHARMACEUTICAL COMPOSITIONS IN TABLETS OBTAINED WITH SUCH PROCEDURE | |
JO1881B1 (en) | Multiple unit tableted dosage from ii |